Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-8 of 8
Keywords: cardioprotection
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
In Collection
Cardiovascular-Oncology
Petra Kollárová-Brázdová, Olga Lenčová-Popelová, Galina Karabanovich, Júlia Kocúrová-Lengvarská, Jan Kubeš, Nela Váňová, Yvona Mazurová, Michaela Adamcová, Anna Jirkovská, Magdalena Holečková, Tomáš Šimůnek, Petra Štěrbová-Kovaříková, Jaroslav Roh, Martin Štěrba
Journal:
Clinical Science
Clin Sci (Lond) (2021) 135 (15): 1897–1914.
Published: 10 August 2021
... drugs such as doxorubicin or daunorubicin (DAU) can cause serious myocardial injury and chronic cardiac dysfunction in cancer survivors. A bisdioxopiperazine agent dexrazoxane (DEX) has been developed as a cardioprotective drug to prevent these adverse events, but it is uncertain whether it is the best...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2020) 134 (1): 71–72.
Published: 14 January 2020
..., Correspondence: Naseer Ahmed ( [email protected] ) © 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2020 antioxidants cardioprotection galectins peroxiredoxins First, the authors stated that Galectin-3 (Gal-3) significantly reduced ( P <0.05...
Articles
Lei-Lei Ma, Yang Li, Pei-Pei Yin, Fei-Juan Kong, Jun-Jie Guo, Hong-Tao Shi, Jian-Bing Zhu, Yun-Zeng Zou, Jun-Bo Ge
Journal:
Clinical Science
Clin Sci (Lond) (2018) 132 (1): 93–110.
Published: 11 January 2018
... exerts cardioprotective effects against myocardial ischemia/reperfusion (MI/R) injury in normal animals, whether rapamycin-elicited cardioprotection is altered in the presence of LVH has yet to be determined. Pressure overload induced cardiac hypertrophied mice and sham-operated controls were exposed...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2015) 129 (12): 1173–1193.
Published: 11 November 2015
... and death are apoptosis, excessive autophagy and oxidative stress. HGF counteracts these detrimental processes through pro-survival and antioxidant activities, thus emerging as a powerful cardioprotective agent. After MI (myocardial infarction), HGF levels increase steeply in blood circulation [ 19...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2011) 120 (6): 219–229.
Published: 03 December 2010
... functions both in physiology and pathophysiology of disease. Although its role in blood pressure regulation and interaction with NO is controversial, H 2 S, through its anti-apoptotic, anti-inflammatory and antioxidant effects, has demonstrated significant cardioprotection. As a result, a number of sulfide...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2008) 114 (2): 157–164.
Published: 11 December 2007
... to cause cardiomyocyte hypertrophy. Furthermore, hypertrophy in vivo , as well as in cell models, was associated with an increased expression of α 1A -AR mRNA [ 14 , 15 ]. However, recent studies have suggested, on the contrary, that α 1A -ARs are cardioprotective [ 16 , 17 ]. In the present study, we...
Articles
Dimitrios A. Elaiopoulos, Dimitrios G. Tsalikakis, Maria G. Agelaki, Giannis G. Baltogiannis, Agathokleia C. Mitsi, Dimitrios I. Fotiadis, Theofilos M. Kolettis
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (7): 385–391.
Published: 01 March 2007
...-mail [email protected] ). 20 7 2006 2 10 2006 9 11 2006 9 11 2006 The Biochemical Society 2007 action potential cardioprotection growth hormone (GH) insulin-like growth factor-1 (IGF-1) myocardial infarction ventricular arrhythmia MI (myocardial infarction...
Articles
Jorge Berlanga, Danay Cibrian, Luis Guevara, Heberto Dominguez, Jose S. Alba, Alina Seralena, Gerardo Guillén, Ernesto López-Mola, Pedro López-Saura, Alberto Rodriguez, Brumny Perez, Diana Garcia, Nelson S. Vispo
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (4): 241–250.
Published: 17 January 2007
... manner. Correspondence: Dr Jorge Berlanga (email [email protected] ). 4 5 2006 7 9 2006 21 9 2006 21 9 2006 The Biochemical Society 2007 cardioprotection growth-hormone-releasing peptide 6 (GHRP6) infarction ischaemia myocardium necrosis...